Declining incidence of contralateral breast cancer in the United States from 1975 to 2006 - Wikidata - awgldk - TriplyDB

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

http://www.wikidata.org/entity/Q34866230

about

Contralateral prophylactic mastectomy: current perspectives Decision-Making in the Surgical Treatment of Breast Cancer: Factors Influencing Women's Choices for Mastectomy and Breast Conserving Surgery Oncologic safety of conservative mastectomy in the therapeutic setting Lobular breast cancer series: imaging.AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review.Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.Incidence of Surgical Site Infection Following Mastectomy With and Without Immediate Reconstruction Using Private Insurer Claims Data.Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer.Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics.Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis Invasive mucinous carcinoma arising in ectopic axillary breast tissue: a case report and literature review.Decision Regret following Treatment for Localized Breast Cancer: Is Regret Stable Over Time?The Manchester guidelines for contralateral risk-reducing mastectomy Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.Breast Cancer in the Elderly: Is MRI Helpful?Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction.Declining second primary ovarian cancer after first primary breast cancer.Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing Trend Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ Preoperative Breast Magnetic Resonance Imaging and Contralateral Breast Cancer Occurrence Among Older Women With Breast Cancer.Immediate bilateral nipple-sparing mastectomy and implant-based breast reconstruction.Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics.Contralateral prophylactic mastectomy and its impact on quality of life Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).Association of selected medical conditions with breast cancer risk in Korea.Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.United States trends in the surgical treatment of primary breast cancer.The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in breast cancer: where are we now?Magnetic resonance imaging in patients with newly diagnosed breast cancer: a review of the literature.

P2860

Q26744320-DE1CFC50-6C46-4E0C-9BDC-D1C0D385B074 Q26749389-20BCCCF8-3F69-4840-9845-0E69099FE899 Q26768209-D4E749B8-3C96-46B1-A959-2A99CBB28EF8 Q26827192-54DCEEFB-7F38-4287-A77B-634CAC1821D2 Q30318240-09BFDD88-4186-46A8-A008-37F66A73224C Q30395721-8E628CE2-1219-44B1-B23C-737D0B81A4AE Q30415050-EEAB7A92-3C83-4D42-A88D-D9401FCA7452 Q30964042-54A665D6-25D0-46AD-ADA8-A654CE7271E7 Q31118195-1A9472BA-3CDF-4EA6-8333-DD7A9A50ABDF Q33739428-1650DEBC-6A63-4B03-A57B-FF8EC7D9AA99 Q33767098-ACDF84DC-21ED-4ED3-982E-90A6CA578E67 Q33919320-A987BA17-96EA-4C82-827A-3CD1F909EE7D Q34441602-53B0A026-AC46-4550-9911-803DA2A79F3D Q34513583-A4382E93-F852-4944-9F0A-ACA60A0FC612 Q34629071-CF32F605-160B-4E99-8780-67216006AED0 Q34678705-91F253A6-9D06-4F15-ABA7-13276789EDA4 Q35073191-42A8AA7E-6E6E-420D-AE58-4DFFE1D3B2D2 Q35192288-1899156A-C296-4CA3-BB81-20A9E5C057E4 Q35208703-15C387F6-4092-467A-B912-435A7E41EE16 Q35582455-53FCA035-8FC3-44B1-B43A-C3965A6C8889 Q35923270-95E790FB-C439-48F1-AB58-D9FB61443D14 Q35998644-B9EC1039-E53B-4197-839E-EFA06F4B3885 Q36137506-DF763865-2459-4A48-A1FA-03BA0AE5EEE1 Q36264890-6211D437-0BE7-41E2-826C-2C72D4249AE9 Q36436637-950D856A-E86B-4D3C-8D0A-2BF7294D241F Q36554681-E8DA1613-232A-4183-8BA1-3AD4F9F00165 Q36615095-6357F66C-42E4-4289-9DBC-D4E3C03335E1 Q36734744-CFECA987-EA2D-4BA1-A43E-4B1AB9B57EEF Q36812287-AE03F564-3E79-468C-B4AA-2ED552317647 Q36820188-00DB7669-9AED-4BEC-A120-85B377E5BDA1 Q36914472-345C76C0-A685-4037-8C50-47633D70C255 Q36972997-C0982258-9018-4CFF-BA30-BEC15B029763 Q37069660-58A711DD-3034-4663-9133-0A489AC8F9AF Q37147521-86848600-500A-4AE2-B8C1-95E0270FF71D Q37267678-C57E5AB1-CD6A-4D06-823B-0C4F485BCFCE Q37385078-87B9A6D0-1D4D-4509-A9D4-8CB96C316A3B Q37669779-AB2A37F2-2255-4AAF-9B0B-54D9F64F484F Q37986554-C1A46FE8-1282-4B23-B707-177E827DF9BD Q38154495-E51D0DF9-C83F-4E1B-980A-98110D45B7F4 Q38206146-99E4B18C-F7A4-4392-9675-B3F9AF6011E4

P2860

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

http://www.wikidata.org/entity/Q34866230

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@ast

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@en

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@nl

type

label

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@ast

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@en

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@nl

prefLabel

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@ast

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@en

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@nl

P1433

Q34866230-5368AECD-1BF5-4FBA-9EF9-1B875C0B3FEB

P1476

Q34866230-A9F0AC48-5442-453F-A792-B4CC68AE8C06

P2093

Q34866230-2F8D5D0E-3157-4F19-9AB0-5A32DBED76D9

Q34866230-79AD4B35-555F-490F-BF24-A75C6FA870BF

Q34866230-90046EF3-1B02-4981-A80C-F61851AB5ECD

Q34866230-EFBF7324-1C58-47DA-A502-8CA5DAB89A1D

Q34866230-F1E15408-0CB0-41EF-A9B1-E8CB96B6BA5E

P2860

Q34866230-002877D5-5EDF-4F52-A321-10D961626CE1

Q34866230-0B940DF2-B99A-4B4F-95D3-C93ED2FA28E2

Q34866230-1157A947-CF0C-4C0D-B3BB-2005500C5328

Q34866230-11BEA022-3766-41C2-A173-7D50162A8EA5

Q34866230-213E8173-A678-4187-B207-42F6101069A1

Q34866230-363F7D50-D7D7-4EDB-8F98-4C6C9C40DC60

Q34866230-3BD088E6-052E-4920-9C91-F662E802CEC8

Q34866230-5463C419-7BD7-453E-8120-10C506C73E85

Q34866230-6004BAEB-13B2-4A93-A553-DD85A84A7CC3

Q34866230-73DAB517-E1A3-4CD4-A5E3-3E35C54545FD

P304

Q34866230-C3059553-39E6-4670-84ED-8B7047E25171

P31

Q34866230-5DBCE4F7-4AC3-4C93-A1B6-4BE3529B97DD

P356

Q34866230-FE3E44BD-5E6C-4327-94B4-FD7D0D7BA02D

P407

Q34866230-CC720FD2-F123-48E1-A011-59444684770F

P433

Q34866230-4CB6BF9E-FA8A-4183-8CE4-E6CB7854E01F

P478

Q34866230-68145152-44E1-419F-8B33-AB46C41AA3BF

P50

Q34866230-F7EF970D-55B1-4004-BEB4-C575FB1B40E3

P577

Q34866230-0E189765-3094-4A09-A3B4-F2DB1EEA2CAA

P5875

Q34866230-397DF12F-543F-4F0F-9743-0BC074B1DAA2

P698

Q34866230-512C9E3D-C5B6-4412-B928-9D86C422C0E7

P921

Q34866230-527F5259-ABE0-4304-9871-5DEC73F938CA

P932

Q34866230-B69AB387-B1AE-488B-83EA-099057429FB0

P356

JCO.2010.32.7395

P1433

Journal of Clinical Oncology

P1476

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006

@en

P2093

Amy Berrington de González

http://www.w3.org/2001/XMLSchema#string

Hazel B Nichols

http://www.w3.org/2001/XMLSchema#string

James V Lacey

http://www.w3.org/2001/XMLSchema#string

Philip S Rosenberg

http://www.w3.org/2001/XMLSchema#string

William F Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study.

Second primary breast cancer occurrence according to hormone receptor status

Qualitative age interactions in breast cancer studies: mind the gap.

Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015.

Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

Quantifying epidemiologic risk factors using non-parametric regression: model selection remains the greatest challenge.

P304

1564-1569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.32.7395

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Amy Berrington de González

P577

2011-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50394799

http://www.w3.org/2001/XMLSchema#string

P698

21402610

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

3082975

http://www.w3.org/2001/XMLSchema#string